T1	chemical 0 11	Cannabidiol
T2	chemical 16 28	fenfluramine
T3	disease_or_phenotypic_feature 70 93	Lennox Gastaut syndrome
T4	disease_or_phenotypic_feature 170 177	non-CPP
T5	chemical 170 177	non-CPP
T6	chemical 313 317	drug
T7	disease_or_phenotypic_feature 330 337	disease
T8	chemical 432 439	solvent
T9	disease_or_phenotypic_feature 474 484	dependence
T10	chemical 511 518	solvent
T11	chemical 604 613	psoralens
T12	missed_disease_or_phenotypic_feature 722 732	psioraisis
T13	disease_or_phenotypic_feature 734 742	vitiligo
T14	corrected_disease_or_phenotypic_feature 747 768	skin-related disorder
T15	disease_or_phenotypic_feature 760 768	disorder
T16	chemical 799 804	group
T17	chemical 850 855	group
T18	disease_or_phenotypic_feature 866 877	post-trauma
T19	disease_or_phenotypic_feature 969 984	obesity-related
T20	disease_or_phenotypic_feature 1041 1047	trauma
T21	chemical 1143 1153	biological
T22	chemical 1250 1259	Oxidative
T23	disease_or_phenotypic_feature 1286 1301	Crohn's Disease
T24	chemical 1380 1391	Montelukast
T25	disease_or_phenotypic_feature 1393 1397	MNK)
T26	chemical 1434 1445	antioxidant
T27	chemical 1483 1491	adjuvant
T28	disease_or_phenotypic_feature 1517 1543	non-small cell lung cancer
T29	chemical 1770 1774	DCIS
T30	disease_or_phenotypic_feature 1770 1774	DCIS
T31	corrected_disease_or_phenotypic_feature 1955 1976	ischemic brain injury
T32	disease_or_phenotypic_feature 1964 1976	brain injury
T33	corrected_chemical 1997 2009	free radical
T34	corrected_disease_or_phenotypic_feature 1997 2016	free radical injury
T35	chemical 2002 2009	radical
T36	disease_or_phenotypic_feature 2010 2016	injury
T37	disease_or_phenotypic_feature 2191 2199	cataract
T38	disease_or_phenotypic_feature 2222 2230	syndrome
T39	disease_or_phenotypic_feature 2232 2240	cataract
T40	disease_or_phenotypic_feature 2263 2271	glaucoma
T41	disease_or_phenotypic_feature 2277 2285	cataract
T42	disease_or_phenotypic_feature 2290 2317	primary open-angle glaucoma
T43	chemical 2389 2394	group
T44	disease_or_phenotypic_feature 2443 2451	syndrome
T45	chemical 2572 2585	messenger RNA
T46	disease_or_phenotypic_feature 2654 2675	breast/ovarian cancer
T47	disease_or_phenotypic_feature 2744 2749	tumor
T48	chemical 2817 2835	apoptosisâ€‘inducing
T49	chemical 2836 2842	ligand
T50	chemical 2882 2887	group
T51	chemical 3058 3069	biochemical
T52	disease_or_phenotypic_feature 3143 3152	condition
T53	disease_or_phenotypic_feature 3266 3277	CRISPR-Cas9
T54	chemical 3352 3360	proteins
T55	disease_or_phenotypic_feature 3381 3391	CRISPR-Cas
T56	chemical 3435 3442	Melanin
T57	disease_or_phenotypic_feature 3493 3512	Parkinson's Disease
T58	disease_or_phenotypic_feature 3539 3547	Melanoma
T59	chemical 3621 3631	hemoglobin
T60	disease_or_phenotypic_feature 3741 3750	infection
T61	disease_or_phenotypic_feature 3803 3809	cancer
T62	disease_or_phenotypic_feature 3814 3824	non-cancer
T63	missed_disease_or_phenotypic_feature 3839 3854	chronic fatigue
T64	missed_chemical 3881 3890	Molecular
T65	chemical 3916 3928	antioxidants
T66	chemical 3956 3964	electron
T67	missed_disease_or_phenotypic_feature 4013 4028	chronic fatigue
T68	chemical 4105 4114	oxidative
R1	treats Arg1:T64 Arg2:T67
R2	treats Arg1:T2 Arg2:T3
R3	causes_or_contributes_to Arg1:T33 Arg2:T34
R4	treats Arg1:T1 Arg2:T3
R5	treats Arg1:T11 Arg2:T12
R6	treats Arg1:T11 Arg2:T13
R7	treats Arg1:T11 Arg2:T14
R8	treats Arg1:T65 Arg2:T67
R9	treats Arg1:T6 Arg2:T7
